Jacqueline Scanlan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Philadelphia, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sara V. Ponessa, as attorney-in-fact for Jacqueline Scanlan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jacqueline Scanlan

Form 4 holding Executive VP & Chief HRO

FMC CORP

Security class
Stock Option (Right to Buy)
Shares / value
44,808
Estimated value
$2,494,461
Report date
21 Feb 2025
Price
$55.67
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive VP & Chief HRO

FMC CORP

Security class
Common Stock
Shares / value
68,695
Estimated value
$1,004,320
Report date
23 Feb 2026
Price
$14.62
Ownership
Direct
Form 4 holding SVP, Global Human Resources

HAEMONETICS CORP

Security class
Common Stock
Shares / value
4,216
Estimated value
$364,220
Report date
07 Jun 2021
Price
$86.39
Ownership
Direct

Insider Reports Filed by Jacqueline Scanlan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .